Clinical Trial Update: A Study to Evaluate the Pharmacokinetics and Safety of ASC16 Tablets in Healthy Volunteers in China [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetics and safety study of ASC16 tablets in healthy volunteers in China has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• ASC16

Snippet

Sponsor: Ascletis Pharmaceuticals Co., Ltd. | Conditions: Chronic Hepatitis c | Phase 1 | Status: COMPLETED